Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Bitton

Showing results (141-150 of 200) with videos related to

Pageof 20
Sort By:
Gut|May 20, 2016
Appendectomy does not decrease the risk of future colectomy in UC: results from a large cohort and meta-analysisAlyssa Parian, Berkeley Limketkai, Joyce Koh, et al.
Redox Biology|May 18, 2026
Serum thiol redox-related alterations in asymptomatic first-degree relatives are associated with future Crohn's diseaseKaiwen Mu, Mingyue Xue, Hien Q Huynh, et al.
Journal of the Canadian Association of Gastroenterology|September 7, 2023
The 2023 Impact of Inflammatory Bowel Disease in Canada: Executive SummaryJoseph W Windsor, M Ellen Kuenzig, Sanjay K Murthy, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|September 17, 2004
Canadian Association of Gastroenterology Clinical Practice Guidelines: the use of infliximab in Crohn's diseaseRemo Panaccione, Richard N Fedorak, Guy Aumais, et al.
Nature Genetics|December 23, 2008
Common variants in the NLRP3 region contribute to Crohn's disease susceptibilityAlexandra-Chloé Villani, Mathieu Lemire, Geneviève Fortin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 3, 2014
The probiotic VSL#3 has anti-inflammatory effects and could reduce endoscopic recurrence after surgery for Crohn's diseaseRichard N Fedorak, Brian G Feagan, Naomi Hotte, et al.
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Children and Expectant Mothers With Inflammatory Bowel DiseaseEric I Benchimol, Matthew W Carroll, Rose Geist, et al.
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: COVID-19 Vaccines-Biology, Current Evidence and RecommendationsSanjay K Murthy, M Ellen Kuenzig, Joseph W Windsor, et al.
Inflammatory Bowel Diseases|March 14, 2023
Hospitalization Rates for Inflammatory Bowel Disease Are Decreasing Over Time: A Population-based Cohort StudyMichael J Buie, Stephanie Coward, Abdel-Aziz Shaheen, et al.
Gastroenterology|November 26, 2013
Methotrexate in combination with infliximab is no more effective than infliximab alone in patients with Crohn's diseaseBrian G Feagan, John W D McDonald, Remo Panaccione, et al.
Pageof 20

Showing results (141-150 of 200) with videos related to

Sort By:
Pageof 20
Gut|May 20, 2016
Appendectomy does not decrease the risk of future colectomy in UC: results from a large cohort and meta-analysisAlyssa Parian, Berkeley Limketkai, Joyce Koh, et al.
Redox Biology|May 18, 2026
Serum thiol redox-related alterations in asymptomatic first-degree relatives are associated with future Crohn's diseaseKaiwen Mu, Mingyue Xue, Hien Q Huynh, et al.
Journal of the Canadian Association of Gastroenterology|September 7, 2023
The 2023 Impact of Inflammatory Bowel Disease in Canada: Executive SummaryJoseph W Windsor, M Ellen Kuenzig, Sanjay K Murthy, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|September 17, 2004
Canadian Association of Gastroenterology Clinical Practice Guidelines: the use of infliximab in Crohn's diseaseRemo Panaccione, Richard N Fedorak, Guy Aumais, et al.
Nature Genetics|December 23, 2008
Common variants in the NLRP3 region contribute to Crohn's disease susceptibilityAlexandra-Chloé Villani, Mathieu Lemire, Geneviève Fortin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 3, 2014
The probiotic VSL#3 has anti-inflammatory effects and could reduce endoscopic recurrence after surgery for Crohn's diseaseRichard N Fedorak, Brian G Feagan, Naomi Hotte, et al.
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Children and Expectant Mothers With Inflammatory Bowel DiseaseEric I Benchimol, Matthew W Carroll, Rose Geist, et al.
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: COVID-19 Vaccines-Biology, Current Evidence and RecommendationsSanjay K Murthy, M Ellen Kuenzig, Joseph W Windsor, et al.
Inflammatory Bowel Diseases|March 14, 2023
Hospitalization Rates for Inflammatory Bowel Disease Are Decreasing Over Time: A Population-based Cohort StudyMichael J Buie, Stephanie Coward, Abdel-Aziz Shaheen, et al.
Gastroenterology|November 26, 2013
Methotrexate in combination with infliximab is no more effective than infliximab alone in patients with Crohn's diseaseBrian G Feagan, John W D McDonald, Remo Panaccione, et al.
Pageof 20